901 related articles for article (PubMed ID: 16911629)
41. Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria.
Knerr I; Hofer SE; Holterhus PM; Näke A; Rosenbauer J; Weitzel D; Wolf J; Holl RW
Diabet Med; 2007 Dec; 24(12):1478-81. PubMed ID: 17971184
[TBL] [Abstract][Full Text] [Related]
42. A cross-sectional international survey of continuous subcutaneous insulin infusion in 377 children and adolescents with type 1 diabetes mellitus from 10 countries.
Danne T; Battelino T; Kordonouri O; Hanas R; Klinkert C; Ludvigsson J; Barrio R; Aebi C; Gschwend S; Mullis PE; Schumacher U; Zumsteg U; Morandi A; Rabbone I; Cherubini V; Toni S; de Beaufort C; Hindmarsh P; Sumner A; van Waarde WM; van den Berg N; Phillip M
Pediatr Diabetes; 2005 Dec; 6(4):193-8. PubMed ID: 16390387
[TBL] [Abstract][Full Text] [Related]
43. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
Ratzmann KP; Schimke E
Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
[TBL] [Abstract][Full Text] [Related]
44. Quality of diabetes care, diabetes knowledge and risk of severe hypoglycaemia one and four years after participation in a 5-day structured treatment and teaching programme for intensified insulin therapy.
Schiel R; Ulbrich S; Müller UA
Diabetes Metab; 1998 Dec; 24(6):509-14. PubMed ID: 9932217
[TBL] [Abstract][Full Text] [Related]
45. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
[TBL] [Abstract][Full Text] [Related]
46. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
47. Pregnancy outcome and glycemic control in women with type 1 diabetes: a retrospective comparison between CSII and MDI treatment.
Talaviya PA; Saboo BD; Joshi SR; Padhiyar JN; Chandarana HK; Shah SJ; Vyas CK; Shah AN
Diabetes Metab Syndr; 2013; 7(2):68-71. PubMed ID: 23680243
[TBL] [Abstract][Full Text] [Related]
48. Insulin pump therapy and rapid acting insulin: what have we learned?
Zinman B
Int J Clin Pract Suppl; 2001 Sep; (123):47-50. PubMed ID: 11594299
[TBL] [Abstract][Full Text] [Related]
49. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
50. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Weintrob N; Shalitin S; Phillip M
Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
[TBL] [Abstract][Full Text] [Related]
51. [Evaluation of an intensive treatment education program for type 1 diabetes in a group of adolescents. A two year follow up].
Krochik AG; Mazza CS; Araujo MB; Kovalskys I; Ozuna B; Assad D; Coppola L; Domenech I; Lahera E; Zufriategui Z; Gagliardino JJ
Medicina (B Aires); 2004; 64(2):107-12. PubMed ID: 15628295
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of diabetes with the insulin pump].
Koznarová R; Jirkovská A; Pelikánová T
Cas Lek Cesk; 2001 Apr; 140(8):227-9. PubMed ID: 11392038
[TBL] [Abstract][Full Text] [Related]
53. [A comparison of efficacy and safety in the treatment of hyperglycemia with continuous subcutaneous insulin with insulin pump or multiple insulin injections daily in critical elderly patients].
Huang W; Liu YS; Wang YJ; Long LM; Li X; Wang Y; Yang Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Sep; 20(9):546-9. PubMed ID: 18786316
[TBL] [Abstract][Full Text] [Related]
54. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
55. Parental fear of hypoglycemia: young children treated with continuous subcutaneous insulin infusion.
Patton SR; Dolan LM; Henry R; Powers SW
Pediatr Diabetes; 2007 Dec; 8(6):362-8. PubMed ID: 18036061
[TBL] [Abstract][Full Text] [Related]
56. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
[TBL] [Abstract][Full Text] [Related]
57. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
Oskarsson PR; Lins PE; Backman L; Adamson UC
Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
[TBL] [Abstract][Full Text] [Related]
58. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
59. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
Parkner T; Møller MK; Chen JW; Laursen T; Jørgensen C; Smedegaard JS; Lauritzen T; Christiansen JS
Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
[TBL] [Abstract][Full Text] [Related]
60. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
